INTRODUCTION
Thyroid activity is regulated by two mechanisms; it varies directly with the level of circulating thyrotropin (TSH) and inversely with the iodine content of the thyroid gland itself. Raising the level of thyrotropin increases the uptake and release of iodine by the thyroid, causes the gland to hypertrophy, and influences many metabolic processes within the thyroid (1, 2) . The level of circulating thyrotropin is in turn regulated by a negative feedback between the pituitary and the level of circulating thyroid hormone (1) . This reciprocal relationship between TSH and thyroid hormone has been most elegantly demonstrated by the use of the radioimmunoassay for TSH. When thyroid hormone is low, as in myxedema, TSH is elevated, whereas thyroid hormone replacement reduces the concentration of TSH (3) .
The inverse relationship between the concentration of iodine in the thyroid and the activity of the thyroid gland can be demonstrated in intact and in hypophysectomized rats and thus is independent of TSH. In hypophysectomized rats the weight of the thyroid (4) and its uptake of radioactive iodine (5) were higher if the rats had been iodine depleted before hypophysectomy, and administering thyrotropin to these same two groups of rats produces a greater effect in the iodine-depleted animals (6) . Thus iodine depletion appears to potenitate the effects of thyrotropin. Stimulation of the thyroid gland of hypophysectomized rats with constant amounts of exogenous thyrotropin produced a greater uptake of radioactive iodine in iodine-depleted glands than in glands with normal iodine content (7) . Similar studies in human beings who were acutely depleted of iodine have suggested that the uptake of radioactive iodine by human thyroid may also be regulated, in part, by the intrathyroid content of iodine (8) . In the present studies we have explored the possibility that the intrathyroid content of iodine might also regulate the TSH-induced growth of the thyroid gland and have found that the goitrogenic effects of thyrotropin are indeed augmented by iodine depletion.
METHODS
In the present experiments, 267 hypophysectomized rats weighing 80-100 g were purchased from Charles River Laboratories, Boston, Mass. A similar protocol was followed for all experiments (see Table I ) and minor variations are noted in the legend to each table or figure. Before hypophysectomy 6 rats received a chow diet, 24 rats received a low iodine diet' (mildly iodine-depleted group), and 232 rats received a low iodine diet supplemented with 0.1% propylthiouracil (PTU) (severely iodine-depleted groups). From the time of hypophysectomy all rats were maintained on the low iodine diet supplemented, in all but one experiment (see Table II ) with 0.1% propylthiouracil, and they all received 100 ,ug of cortisone acetate intramuscularly and 0. given as a suspension in peanut oil as a single daily dose ing water to most groups after hypophysectomy and sofor 7 days (thyroid weights, 14.5 ± 0.7 mg/100 g of body dium perchlorate was mixed with the low iodine diet to weight vs. 11.7 + 0.6 mg/100 g of body weight; P <0.05). give 50 jmoles of sodium perchlorate per gram of low
Triiodothyronine was dissolved in alkaline saline and iodine diet and was fed during the period of administra-0.5 ,Ag was injected subcutaneously in a volume of 0.1 ml tion of thyrotropin (Tables IV and V) . Potassium iodide once each day for 5 days/wk after hypophysectomy. was dissolved in distilled water to give 0.3, 3, or 30 ,ug Cortisone acetate was diluted with saline and 100 ug was of iodide per 10 ml and given in the drinking water to given in a volume of 0.1 ml intramuscularly once each one or another of the groups in Table V (Table II ; group 1). After 12 days on a low iodine diet the weight of the thyroid increased to 12.7 mg/100 g of body weight and the iodine content was reduced by one-half (group 2). Addition of 0.1% propylthiouracil to the low iodine diet before hypophysectomy increased the thyroid weight to 32.8 mg/100 g of body weight and depleted the thyroid of more than 99%o of its iodine (group 5). After hypophysectomy the weight of the thyroid declined in all rats (groups 3, 4, 6, 7) but remained consistently heavier than normal (group 1). The iodine content increased substantially after hypophysectomy when the rats were fed only a low iodine diet (Table II; compare groups 5 and 6), but remained almost unchanged if the diet was supplemented with propylthiouracil (Table II [ (Table IV) . To test the effect of circulating levels of iodide on the TSH-induced enlargement of the thyroid gland, iodide was added to the drinking water and both perchlorate and propylthiouracil were added to the food to prevent the uptake of iodide by the thyroid gland. Iodide alone had no effect on thyroid weight, and it did not prevent enlargement of of the thyroid gland in rats treated with thyrotropin (Table V) .
4. The effect of thyrotropin on iodine uptake and intrarat-thyroidal iodine content. During treatment with thyrotropin the iodine content increased in thyroid glands from rats that had been severely depleted of iodine before hypophysectomy (Tables  IV and VI) . Supplementing the diet with propylthiouracil prevented the accumulation of iodine, but did not augment the response to thyrotropin (Table IV) . DISCUSSION The present studies demonstrate the extreme sensitivity of the iodine-depleted thyroid to the goitrogenic effects of thyrotropin, and support the concept that enlargement of the thyroid is inversely related to iodine content. 3 mU of thyrotropin (TSH) were given to 100 g rats in divided doses each day, such that each dose contained only 1 mU of TSH. If this entire dose were immediately absorbed into a blood volume equivalent to 10% of the body weight (i.e., 10 ml), the concentration could reach a level of 0.1 mU/ml, a value five times higher than that of 0.02 mU/ml for serum * Rats were fed a low iodine diet supplemented with 0.1% PTU for 10 or 11 days, (expt. 7) before hypophysectomy. After hypophysectomy they received the same diet and 1% perchlorate in the drinking water for 8 (expt. 8) or 10 days. On the 11th day they were switched to tap water and low iodine diet for the remainder of the experiment. Thyrotropin in saline, 100 mU/100 g of body wt in divided doses each day for 7 days was begun on the 14th or 15th day (exept. 9) after hypophy-
TSH of normal rats, as measured by Bakke and Lawrence (9) . In all likelihood, however, the TSH was not absorbed immediately, and with a half-time in rat serum of only 12 min (9) the levels achieved by a single injection of TSH would probably be less than normal. Moreover, the estimated secretion of TSH from the pituitary each day was 16.8 mU/day (9) or more than five times the quantity of thyrotropin we used to produce significant thyroid enlargement. Further support for the sensitivity of our preparation comes from the observations of Averill (10) who injected or infused TSH and measured the release of radioactive iodine from the thyroid. An infusion of 2.4 mU/hr (i.e., 58 mU/day) significantly increased the release of radioactive iodine from the thyroid, but subcutaneous injection required 4-10 times as much TSH to get comparable results. Thus, the demonstration that thyroid enlargement can be produced by 3 mU/day of TSH given by the subcutaneous route indicates a very high degree of sensitivity.
In contrast to the data on the rats which were severely depleted of iodine are the data on mild depletion and iodine supplementation. When the content of iodine in the thyroid was only slightly depleted, 1000 mU/day of thyrotropin did not increase the weight of the thyroid, a finding which confirms the obesrvations of previous investigators that doses of TSH in excess of 1000 mU/day (or more than 1 mg/day) are usually necessary to produce goiters in normal rats (see Table VII , where the only exception is the study of Albert, Rawson, Riddle, Merrill, and Lennon (11) in which chicks were used). Further support for the inverse relationship between the content of iodine in the thyroid and its growth in response to TSH was presented by Katakai, Yamada, and Shichijo (12) who showed that rats receiving 200 ,tg of iodine daily had a significantly reduced goitrogenic response to 4000 mU of TSH daily.
Iodine depletion not only augments the potential of the thyroid for cellular growth, but also increases its capacity to accumulate and metabolize iodine (4) (5) (6) (7) (8) , even in the absence of TSH. Conversely, high iodine intake suppresses the uptake and metabolism of iodine independently of thyrotropin (13, 14) . VanderLaan and Caplan (7) were the first to suggest that some intracellular iodinated component was acting as a regulator of (13, 15, 16) . Our studies showing that the goitrogenic effect of thyrotropin was not blocked by high levels of circulating iodide are consistent with the hypothesis that it is the intracellular iodine that is regulating the response to TSH. The nature and mechanism by which this intrathyroidal substance influences thyroid function, however, must await further study.
The question of whether propylthiouracil potentiates the goitrogenic effects of thyrotropin has received divergent answers (11, 17, 18) . Astwood and Bissell (17) noted that increase in the weight of thyroid in rats treated with 10 mg of TSH twice daily for 4 days was unaffected by thiouracil, and our findings that PTU did not affect the enlargement of the thyroid in iodine-depleted rats are in agreement with theirs. Albert et al (11) , on the contrary, found that thiouracil potentiated the effects of 400 ug of TSH in chicks fed the goitrogen, and Alexander and Wolff (18) observed that 10 U of TSH daily for 14 days produced somewhat larger thyroid glands in rats which were also receiving propylthiouracil. The apparent potentiation of thyroid enlargement attributed to thiouracil (11, 18) or PTU may have resulted from the increased sensitivity of the iodine-depleted thyroid gland to TSH, rather than to any direct effect of the antithyroid drug on the response to TSH.
Finally, the present experiments may provide some insight into a mechanism for enlargement of the thyroid that does not require an increased release of thyrotropin. The usual sequence of events in the development of thyroid enlargement has been depicted as follows: (1) (19) . There is substantial experimental evidence supporting this sequence of events. A number of mechanisms can reduce the quantity of hormone synthesized by the thyroid gland, including drugs (20) , iodine deficiency (21) , and genetic or acquired defects in hormone synthesis (22, 23) . Moreover, removal of the pituitary prevents the development of goiter in animals fed antithyroid drugs and markedly slows the secretion of hormones from the thyroid gland (1, 20) . Reduction of the levels of circulating thyroid hormone leads to an increased output of thyrotropin by the pituitary (1) .
As impressive as the data for this hypothesis appear, many patients with nontoxic nodular goiter do not have demonstrable reductions in the level of circulating thyroid hormone (23) and recent studies using the radioimmunoassay for measuring plasma TSH in patients with nontoxic goiter have failed to find increased levels of thyrotropin in the plasma in many patients (24) . In addition, studies on goiter formation in iodine-depleted rats by Studer and Greer (25) indicated that the early phases of thyroid enlargement occurred without a measurable increase in TSH or a decrease in PBI, although they did observe a decrease in the iodine content of the thyroid. These authors argued that TSH was probably still elevated during this early period, but that their methods were not sensitive enough to detect it. It is also conceivable, however, that TSH was not elevated, but rather the thyroid had become more sensitive to TSH as a result of the decrease in its iodine content. The concept that elevated levels of TSH may not be necessary to produce some forms of thyroid enlargement might be extended to nodular goiter in man. There is direct evidence that the iodine concentration in nodular tissue is reduced, when compared with paranodular tissue (26) . Moreover, nodular tissue incorporated less radioactive iodine into diisotyrosine and thyronines than paranodular tissue (27) (28) (29) . The mechanism for the decreased iodine content and functional capacity of nodular tissue to synthesize iodothyronines is unknown. However, such a reduction in iodine content could increase the sensitivity of these regions of the thyroid to the goitrogenic effects of thyrotropin and lead to nodular growth. Thus it seems possible that two mechanisms may be involved in thyroid enlargement. The first mechanism involves stimulation of the thyroid by increased levels of circulating thyrotropin and leads to diffuse glandular enlargement. The second mechanism'suggested by the present studies is one in which nodular thyroid enlargement occurs with normal levels of circulating thyrotropin due to the loss of iodine from localized regions of the thyroid and subsequent increased sensitivity of these regions to the goitrogenetic effects of thyrotropin.
